
Call for any questions
0242 2253211

Dr. Nguyen Hoa Anh,
Director ANABIO R&D
Assessment of acute and sub-acute toxicity in oral administration, eyes irritation test, nose irritation test and mucosa irritation test of LiveSpo® NAVAX
Study on application of LiveSpo® Navax in the supportive treatment of acute rhinosinusitis and chronic purulent otitis media
Study on application of LiveSpo® Navax in treatment of Acute Respiratory Tract Infections due to RSV (Respiratory syncytial virus) and influenza virus






On September 15, 2022, the ETC department and ANABIO R&D had a meeting to share at the Department of Pedia...
On July 20th, 2022, the research article regarding nasal-spraying spore probiotics LiveSpo Navax entitled “N...
From June 9-13, 2022, the 2022 International Microbiology Conference took place in Washington DC. The conferen...
On May 18, 2022, LiveSpo Global JSC. held a press conference to establish the Spobiotic Research Center with t...